Showing results (71-80 of 128) with videos related to

Sort By:
Pageof 13
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 31, 2011
Association between calcineurin inhibitor blood concentrations and outcomes after allogeneic hematopoietic cell transplantationRon Ram, Barry Storer, Marco Mielcarek, et al.
Leukemia & Lymphoma|May 7, 2015
Infections associated with bendamustine containing regimens in hematological patients: a retrospective multi-center studyAnat Gafter-Gvili, Elena Ribakovsky, Nadav Mizrahi, et al.
Leukemia & Lymphoma|May 20, 2021
Eltrombopag for enhancement of platelet engraftment in patients undergoing allogeneic cord blood transplantationOren Pasvolsky, Liat Shargian, Uri Rozovski, et al.
Transplantation and Cellular Therapy|February 19, 2022
Immunogenicity of a Third Dose of the BNT162b2 mRNA Covid-19 Vaccine in Patients with Impaired B Cell Reconstitution After Cellular Therapy-A Single Center Prospective Cohort StudyRon Ram, Tal Freund, Tami Halperin, et al.
Annals of Hematology|September 13, 2019
Midostaurin in combination with intensive chemotherapy is safe and associated with improved remission rates and higher transplantation rates in first remission-a multi-center historical control studyTamar Berger, Uri Rozovski, Yakir Moshe, et al.
American Journal of Hematology|April 1, 2018
Treatment patterns and clinical outcomes in high-risk newly diagnosed multiple myeloma patients carrying the 17p deletion: An observational multi-center retrospective studyYael C Cohen, Avi Saranga, Moshe E Gatt, et al.
American Journal of Hematology|June 19, 2019
Characteristics, management and outcome of DLBCL patients, presenting with simultaneous systemic and CNS disease at diagnosis: A retrospective multicenter studyChava Perry, Sharon Ben Barouch, Neta Goldschmidt, et al.
Annals of Hematology|June 22, 2022
Venetoclax in combination with FLAG-IDA-based protocol for patients with acute myeloid leukemia: a real-world analysisOfir Wolach, Avraham Frisch, Liat Shargian, et al.
European Journal of Haematology|September 26, 2021
Characteristics and recognition of early infections in patients treated with commercial anti-CD19 CAR-T cellsOfrat Beyar-Katz, Nino Kikozashvili, Yael Bar On, et al.
Leukemia & Lymphoma|April 21, 2021
Post-transplantation maintenance with sorafenib or midostaurin for FLT3 positive AML patients - a multicenter retrospective observational studyShai Shimony, Moshe Yeshurun, Ofir Wolach, et al.
Pageof 13